Annual Total Liabilities
$106.66 M
-$5.55 M-4.95%
December 31, 2023
Summary
- As of February 7, 2025, PRQR annual total liabilities is $106.66 million, with the most recent change of -$5.55 million (-4.95%) on December 31, 2023.
- During the last 3 years, PRQR annual total liabilities has risen by +$54.78 million (+105.58%).
- PRQR annual total liabilities is now -4.95% below its all-time high of $112.22 million, reached on December 31, 2022.
Performance
PRQR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$91.44 M
+$116.80 K+0.13%
September 1, 2024
Summary
- As of February 7, 2025, PRQR quarterly total liabilities is $91.44 million, with the most recent change of +$116.80 thousand (+0.13%) on September 1, 2024.
- Over the past year, PRQR quarterly total liabilities has dropped by -$9.85 million (-9.73%).
- PRQR quarterly total liabilities is now -18.51% below its all-time high of $112.22 million, reached on December 31, 2022.
Performance
PRQR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PRQR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.0% | -9.7% |
| 3 y3 years | +105.6% | +62.7% |
| 5 y5 years | +431.4% | +62.7% |
PRQR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.0% | at low | -18.5% | +62.7% |
| 5 y | 5-year | -5.0% | +301.7% | -18.5% | +483.6% |
| alltime | all time | -5.0% | >+9999.0% | -18.5% | +1341.7% |
ProQR Therapeutics NV Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $91.44 M(+0.1%) |
| Jun 2024 | - | $91.32 M(-5.0%) |
| Mar 2024 | - | $96.17 M(-9.8%) |
| Dec 2023 | $106.66 M(-4.9%) | $106.66 M(+5.3%) |
| Sep 2023 | - | $101.29 M(-3.4%) |
| Jun 2023 | - | $104.86 M(-3.2%) |
| Mar 2023 | - | $108.29 M(-3.5%) |
| Dec 2022 | $112.22 M(+2.9%) | $112.22 M(+99.6%) |
| Sep 2022 | - | $56.21 M(-41.6%) |
| Jun 2022 | - | $96.18 M(-4.3%) |
| Mar 2022 | - | $100.47 M(-7.9%) |
| Dec 2021 | $109.09 M(+110.3%) | $109.09 M(+39.7%) |
| Sep 2021 | - | $78.07 M(+46.4%) |
| Jun 2021 | - | $53.33 M(+7.2%) |
| Mar 2021 | - | $49.74 M(-4.1%) |
| Dec 2020 | $51.88 M(+95.4%) | $51.88 M(+5.0%) |
| Sep 2020 | - | $49.43 M(+215.4%) |
| Jun 2020 | - | $15.67 M(-36.2%) |
| Mar 2020 | - | $24.58 M(-7.4%) |
| Dec 2019 | $26.55 M | $26.55 M(+12.1%) |
| Sep 2019 | - | $23.68 M(+4.0%) |
| Jun 2019 | - | $22.76 M(-2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $23.37 M(+16.4%) |
| Dec 2018 | $20.07 M(+21.4%) | $20.07 M(+4.1%) |
| Sep 2018 | - | $19.28 M(+12.6%) |
| Jun 2018 | - | $17.12 M(+8.4%) |
| Mar 2018 | - | $15.80 M(-4.4%) |
| Dec 2017 | $16.53 M(+26.0%) | $16.53 M(+9.1%) |
| Sep 2017 | - | $15.14 M(+14.1%) |
| Jun 2017 | - | $13.27 M(+0.3%) |
| Mar 2017 | - | $13.24 M(+0.9%) |
| Dec 2016 | $13.12 M(+16.4%) | $13.12 M(+2.7%) |
| Sep 2016 | - | $12.77 M(-11.7%) |
| Jun 2016 | - | $14.46 M(+13.9%) |
| Mar 2016 | - | $12.69 M(+12.6%) |
| Dec 2015 | $11.27 M(+58.6%) | $11.27 M(+9.5%) |
| Sep 2015 | - | $10.29 M(-2.3%) |
| Jun 2015 | - | $10.54 M(+27.1%) |
| Mar 2015 | - | $8.29 M(+16.7%) |
| Dec 2014 | $7.11 M(+12.0%) | $7.11 M(+3.2%) |
| Sep 2014 | - | $6.89 M(-0.6%) |
| Jun 2014 | - | $6.93 M(+9.3%) |
| Dec 2013 | $6.34 M(+1906.4%) | $6.34 M |
| Dec 2012 | $316.10 K | - |
FAQ
- What is ProQR Therapeutics NV annual total liabilities?
- What is the all time high annual total liabilities for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV annual total liabilities year-on-year change?
- What is ProQR Therapeutics NV quarterly total liabilities?
- What is the all time high quarterly total liabilities for ProQR Therapeutics NV?
- What is ProQR Therapeutics NV quarterly total liabilities year-on-year change?
What is ProQR Therapeutics NV annual total liabilities?
The current annual total liabilities of PRQR is $106.66 M
What is the all time high annual total liabilities for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high annual total liabilities is $112.22 M
What is ProQR Therapeutics NV annual total liabilities year-on-year change?
Over the past year, PRQR annual total liabilities has changed by -$5.55 M (-4.95%)
What is ProQR Therapeutics NV quarterly total liabilities?
The current quarterly total liabilities of PRQR is $91.44 M
What is the all time high quarterly total liabilities for ProQR Therapeutics NV?
ProQR Therapeutics NV all-time high quarterly total liabilities is $112.22 M
What is ProQR Therapeutics NV quarterly total liabilities year-on-year change?
Over the past year, PRQR quarterly total liabilities has changed by -$9.85 M (-9.73%)